Alignment Healthcare, Inc. reports developments tied to its Medicare Advantage business for seniors, including health plan membership, revenue growth, adjusted gross profit, adjusted EBITDA and annual guidance. The company operates under the Alignment Health consumer brand and works with local provider partners to deliver coordinated care through a customized care model, a 24/7 concierge care team and the AVA® technology platform.
Recurring updates include quarterly and full-year results, membership outlooks for HMO and PPO contracts, Medicare Advantage operating trends, investor conference presentations and registered offerings involving common stock. News also follows the company's expansion of health plan offerings and national footprint within senior care.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation in two major healthcare conferences in March 2025. The company will present at the Leerink Global Healthcare Conference on Tuesday, March 11, at 3:40 p.m. EDT, followed by a presentation at the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, at 10:30 a.m. EDT.
Both presentations will be accessible via webcast, with replays available on Alignment's investor relations website at ir.alignmenthealth.com.
Alignment Healthcare (ALHC) reported strong growth in its Q4 and full-year 2024 results. Health plan membership reached 189,100 as of December 31, 2024, marking a 58.6% increase year-over-year. The company achieved its first full year of positive adjusted EBITDA as a public company.
Q4 2024 highlights include total revenue of $701.2 million, up 50.7% year-over-year, with a medical benefits ratio of 87.5%. The company recorded an adjusted EBITDA of $1.4 million, despite a net loss of $(31.1) million.
For full-year 2024, total revenue reached $2,703.6 million, increasing 48.3% year-over-year, with an adjusted EBITDA of $1.3 million and a net loss of $(128.1) million. Looking ahead, ALHC provided 2025 revenue guidance of $3.72-3.78 billion, projecting 37.6-39.6% growth, with adjusted EBITDA expected between $35-60 million.
Alignment Healthcare (NASDAQ: ALHC) has scheduled its fourth quarter and full-year 2024 financial results announcement for Thursday, February 27, 2025, after market close. The company will host a conference call at 5 p.m. EST to discuss the results.
A live audio webcast will be accessible at ir.alignmenthealth.com. The webcast replay will be available for approximately 12 months after the call for on-demand listening.
Alignment Healthcare (NASDAQ: ALHC) reported significant growth with 209,900 members as of January 1, representing a 35% year-over-year increase in health plan membership. The company projects 225,000 to 231,000 members by December 31, 2025, indicating 22-25% growth from year-end 2024.
The company reaffirmed its full-year 2024 guidance and expressed confidence in achieving consensus adjusted EBITDA of approximately $40 million in 2025. Additionally, Dawn Maroney has been promoted to President of Alignment Healthcare, where she will oversee day-to-day operations.
Notable achievements include having 98% of members enrolled in 4-star or above rated plans for 2025, maintaining a 5-star rating for North Carolina and Nevada HMO contracts, and earning 4.5 stars for California PPO and 4 stars for California HMO in 2025.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Wednesday, January 15, at 11:15 a.m. PST. Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at ir.alignmenthealth.com.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Wednesday, January 15, at 1:30 p.m. PST. Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at ir.alignmenthealth.com.
Alignment Health Plan has expanded its Medicare Advantage network in Arizona through an enhanced agreement with Arizona Priority Care. The expansion gives members access to over 4,500 primary care providers, specialists, and hospitals, including Banner Health facilities, throughout Maricopa County. The network now encompasses major hospital systems including Abrazo Health, HonorHealth, and Dignity Health. For 2025, Alignment offers four HMO options in Maricopa County, including specialized plans for chronic conditions and Spanish-speaking members. The enhanced partnership builds upon their initial 2022 agreement.
Alignment Healthcare (NASDAQ: ALHC) has announced a private placement of $330 million in 4.25% Convertible Senior Notes due 2029. The notes will be convertible at an initial price of $16.04, representing a 25% premium to the stock's closing price on November 14, 2024. The company expects to receive net proceeds of approximately $321.05 million, which will be used to repay its existing term loan facility (currently at SOFR + 6.5%) and for general corporate purposes. The placement agent plans to purchase about 3.442 million shares of company stock in private transactions.
Alignment Healthcare (NASDAQ: ALHC) has announced its participation in two upcoming investor conferences. The company will present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on November 13 at 3:30 p.m. PST, and at the Stephens Annual Investment Conference in Nashville, Tennessee on November 20 at 9 a.m. CST. Both presentations will be available via webcast and replay on Alignment's investor relations website.
Alignment Health Plan has been recognized as one of only six insurers named to U.S. News & World Report's 2025 Best Insurance Companies for Medicare Advantage Honor Roll in California. The company's PPO plans achieved 4.5 stars and HMO plans maintained 4 stars from CMS. For 2025, Alignment is offering HMO, PPO, and special needs plans across 22 California counties, serving nearly 5.8 million Medicare-eligible seniors. Key features include $0 to low premium plans, $0 copay for Part D generic drugs in HMO plans, and two new chronic condition SNPs for lung and mental health conditions.